To further investigate whether hSPAR suppresses breast cancer cell proliferation through mTOR signaling, we transfected control, ΔATG1 + 2, or Flag-hSPAR plasmids into MDA-MB-231 cells in which we blocked mTOR signaling using rapamycin, followed by EdU incorporation assays. This evidence concerns the gene MTOR and breast carcinoma.